These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36066241)

  • 1. Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant
    Stanton RA; Campbell D; McAllister GA; Breaker E; Adamczyk M; Daniels JB; Lutgring JD; Karlsson M; Schutz K; Jacob JT; Wilson LE; Vaeth E; Li L; Lynfield R; Snippes Vagnone PM; Phipps EC; Hancock EB; Dumyati G; Tsay R; Cassidy PM; Mounsey J; Grass JE; Bulens SN; Walters MS; Halpin AL
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0049622. PubMed ID: 36066241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance.
    Diorio-Toth L; Irum S; Potter RF; Wallace MA; Arslan M; Munir T; Andleeb S; Burnham CD; Dantas G
    Microbiol Spectr; 2022 Jun; 10(3):e0076622. PubMed ID: 35638817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing, multilocus sequence typing, and resistance mechanism of the carbapenem-resistant Pseudomonas aeruginosa in China.
    Zhao X; Qin J; Chen G; Yang C; Wei J; Li W; Jia W
    Microb Pathog; 2024 Jul; 192():106720. PubMed ID: 38815778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal Distribution and Its Association With the Carbapenem Resistance Mechanisms of Carbapenem-Non-Susceptible
    Kim N; Ko SY; Park SY; Kim SY; Lee DE; Kwon KT; Kim YK; Lee JC
    Ann Lab Med; 2024 Sep; 44(5):410-417. PubMed ID: 38433574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla
    PÉrez-VÁzquez M; Sola-Campoy PJ; Zurita ÁM; Ávila A; GÓmez-Bertomeu F; SolÍs S; LÓpez-Urrutia L; GÓnzalez-BarberÁ EM; Cercenado E; Bautista V; Lara N; Aracil B; Oliver A; Campos J; Oteo-Iglesias J;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa.
    Atrissi J; Milan A; Bressan R; Lucafò M; Petix V; Busetti M; Dolzani L; Lagatolla C
    Microbiol Spectr; 2021 Oct; 9(2):e0118621. PubMed ID: 34585948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012.
    Sefraoui I; Berrazeg M; Drissi M; Rolain JM
    Microb Drug Resist; 2014 Apr; 20(2):156-61. PubMed ID: 24320688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY; Ko KS
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypes, carbapenemase carriage, integron diversity and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Bocharova Y; Savinova T; Lazareva A; Polikarpova S; Gordinskaya N; Mayanskiy N; Chebotar I
    Int J Antimicrob Agents; 2020 Apr; 55(4):105899. PubMed ID: 31931151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide genome surveillance of carbapenem-resistant
    Yano H; Hayashi W; Kawakami S; Aoki S; Anzai E; Zuo H; Kitamura N; Hirabayashi A; Kajihara T; Kayama S; Sugawara Y; Yahara K; Sugai M
    Antimicrob Agents Chemother; 2024 May; 68(5):e0166923. PubMed ID: 38564665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y
    Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals.
    Telling K; Laht M; Brauer A; Remm M; Kisand V; Maimets M; Tenson T; Lutsar I
    BMC Infect Dis; 2018 Oct; 18(1):513. PubMed ID: 30309321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and Genetic Characteristics of Clinical Carbapenem-Resistant
    Zhao Y; Chen D; Chen K; Xie M; Guo J; Chan EWC; Xie L; Wang J; Chen E; Chen S; Chen W; Jelsbak L
    Microbiol Spectr; 2023 Jun; 11(3):e0426122. PubMed ID: 37078855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
    Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
    Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.